Difficulty: Medium
Average Score: 80%
Practice
Which of the following benzodiazepines is expected to cause the least amount of adverse effects in the elderly?
Correct answer
D
Rationale
In the context of CNS drugs pharmacology, understanding the effects of benzodiazepines in the elderly is crucial due to age-related changes in drug metabolism and increased sensitivity to adverse effects. In this scenario, the correct answer is D) Oxazepam, as it is expected to cause the least amount of adverse effects in the elderly compared to the other options.
Oxazepam is a benzodiazepine that is primarily metabolized by conjugation, bypassing the hepatic oxidative pathways that are often compromised in the elderly. This means that oxazepam is less likely to accumulate in the elderly population, reducing the risk of drug interactions and adverse effects associated with impaired hepatic function.
A) Chlordiazepoxide and B) Diazepam are metabolized through hepatic oxidative pathways, which can lead to drug accumulation in the elderly and an increased risk of adverse effects such as sedation, confusion, and falls. These benzodiazepines are more likely to cause side effects due to their longer half-lives and active metabolites.
C) Flurazepam is a long-acting benzodiazepine with active metabolites that can accumulate in the elderly, leading to prolonged sedation, cognitive impairment, and an increased risk of falls.
Educationally, understanding the pharmacokinetic and pharmacodynamic differences between benzodiazepines in the elderly population is essential for safe prescribing practices. By recognizing the characteristics of benzodiazepines like oxazepam that are less prone to adverse effects in the elderly, healthcare professionals can minimize the risks associated with CNS drug therapy in this vulnerable population.
Oxazepam is a benzodiazepine that is primarily metabolized by conjugation, bypassing the hepatic oxidative pathways that are often compromised in the elderly. This means that oxazepam is less likely to accumulate in the elderly population, reducing the risk of drug interactions and adverse effects associated with impaired hepatic function.
A) Chlordiazepoxide and B) Diazepam are metabolized through hepatic oxidative pathways, which can lead to drug accumulation in the elderly and an increased risk of adverse effects such as sedation, confusion, and falls. These benzodiazepines are more likely to cause side effects due to their longer half-lives and active metabolites.
C) Flurazepam is a long-acting benzodiazepine with active metabolites that can accumulate in the elderly, leading to prolonged sedation, cognitive impairment, and an increased risk of falls.
Educationally, understanding the pharmacokinetic and pharmacodynamic differences between benzodiazepines in the elderly population is essential for safe prescribing practices. By recognizing the characteristics of benzodiazepines like oxazepam that are less prone to adverse effects in the elderly, healthcare professionals can minimize the risks associated with CNS drug therapy in this vulnerable population.